Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cetuximab activity in dysplastic lesions of the upper aerodigestive tract.
Khan Z, Epstein JB, Marur S, Gillespie MB, Feldman L, Tsai HL, Zhang Z, Wang H, Sciubba J, Ferris R, Grandis JR, Gibson M, Koch W, Tufano R, Westra W, Tsottles N, Ozawa H, Chung C, Califano JA. Khan Z, et al. Among authors: tsottles n. Oral Oncol. 2016 Feb;53:60-6. doi: 10.1016/j.oraloncology.2015.11.016. Epub 2015 Dec 10. Oral Oncol. 2016. PMID: 26686755 Free PMC article. Clinical Trial.
Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60-66].
Khan Z, Epstein JB, Marur S, Boyd Gillespie M, Feldman L, Tsai HL, Zhang Z, Wang H, Sciubba J, Ferris RL, Grandis JR, Gibson M, Koch W, Tufano R, Westra W, Tsottles N, Ozawa H, Chung CH, Califano JA. Khan Z, et al. Among authors: tsottles n. Oral Oncol. 2016 Jun;57:e8. doi: 10.1016/j.oraloncology.2016.03.018. Epub 2016 Apr 13. Oral Oncol. 2016. PMID: 27085635 Free PMC article. No abstract available.
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.
Chung CH, Rudek MA, Kang H, Marur S, John P, Tsottles N, Bonerigo S, Veasey A, Kiess A, Quon H, Cmelak A, Murphy BA, Gilbert J. Chung CH, et al. Among authors: tsottles n. Oral Oncol. 2016 Feb;53:54-9. doi: 10.1016/j.oraloncology.2015.11.020. Epub 2015 Dec 17. Oral Oncol. 2016. PMID: 26705063 Free PMC article. Clinical Trial.
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.
Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Chaudhry MA, Wahl R, Forastiere A, Gillison M. Gilbert J, et al. Among authors: tsottles n. Clin Cancer Res. 2012 Mar 15;18(6):1735-42. doi: 10.1158/1078-0432.CCR-11-2544. Epub 2012 Jan 23. Clin Cancer Res. 2012. PMID: 22271880 Free PMC article. Clinical Trial.
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.
Heath EI, Burtness BA, Kleinberg L, Salem RR, Yang SC, Heitmiller RF, Canto MI, Knisely JP, Topazian M, Montgomery E, Tsottles N, Pithavala Y, Rohmiller B, Collier M, Forastiere AA. Heath EI, et al. Among authors: tsottles n. Invest New Drugs. 2006 Mar;24(2):135-40. doi: 10.1007/s10637-006-5934-5. Invest New Drugs. 2006. PMID: 16502351 Clinical Trial.